Key result
Only 2.4% (95% CI, 1.5-3.2%) of US adults aged 60 to 79 years had indications for antihypertensive treatment under the ASH/ISH 2013 guideline but not under the JNC 8 guideline.
Why the study?
What are the public health implications and differences in treatment indications between the ASH/ISH 2013 and JNC 8 hypertension guidelines for adults aged 60 to 79 years?
Cross-Sectional
What are the public health implications and differences in treatment indications between the ASH/ISH 2013 and JNC 8 hypertension guidelines for adults aged 60 to 79 years?
The discrepant SBP targets between ASH/ISH 2013 and JNC 8 guidelines affect treatment indications for only a small proportion (2.4%) of US adults aged 60 to 79 years, while a much larger group (21.0%) remains untreated or inadequately treated.
Discordant BP targets for ages 60-79 may increase clinical uncertainty; challenges consensus and warrants harmonized recommendations.
Multiple guidelines and statements related to hypertension have recently been published. Much discord has arisen from discrepant treatment and target systolic blood pressure thresholds for individuals aged 60 to 79 years of <150 mm Hg in the guideline published by members assigned to the Eighth Joint National Committee and <140 mm Hg in a statement by the American Society of Hypertension and International Society of Hypertension 2013. We sought to evaluate the public health implications of these differences using data from the 2005 to 2010 National Health and Nutrition Examination Survey (NHANES) cycles. NHANES is an ongoing survey designed to allow characterization of the US population and subpopulations. We found that only .2.4% (95% confidence interval, 1.5.3.2%) of adults aged 60 to 79 years had indications for antihypertensive treatment under the more stringent American Society of Hypertension and International Society of Hypertension 2013 guideline but not under Eighth Joint National Committee. About 65.7% (95% confidence interval, 62.4.69.0%) of adults aged 60 to 79 years had indications for treatment under both guidelines. Furthermore, those with indications for treatment under American Society of Hypertension and International Society of Hypertension 2013 but not under Eighth Joint National Committee generally had higher systolic blood pressure and less favorable lipid profiles compared with those with indications for treatment under both guidelines. Importantly, a larger group, comprising 21.0% (95% confidence interval, 18.7.23.2%) of adults aged 60 to 79 years, had either untreated or inadequately treated hypertension and represents an important group for continued efforts.
No takes yet. Share an insight, caveat, or question.
Murthy et al. (2014) conducted a cross-sectional in Hypertension. American Society of Hypertension and International Society of Hypertension 2013 guideline vs. Eighth Joint National Committee guideline was evaluated on Indications for antihypertensive treatment under ASH/ISH 2013 but not JNC 8 (95% CI 1.5-3.2). Only 2.4% (95% CI, 1.5-3.2%) of US adults aged 60 to 79 years had indications for antihypertensive treatment under the ASH/ISH 2013 guideline but not under the JNC 8 guideline.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: